Surevest’s Biogen BIIB Stock Holding History

Surevest’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6K	Hold	23	–	–	﹤0.01%	307
2022 Q2	$5K	Hold	23	–	–	﹤0.01%	333
2022 Q1	$5K	Sell	23 -4	-15%	-$870	﹤0.01%	310
2021 Q4	$6K	Buy	+27	New	+$6.94K	﹤0.01%	305

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Surevest's BIIB Position: Q3 2022 in Review

Surevest held its Biogen (BIIB) position steady in Q3 2022 at 23 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Surevest first reported a position in BIIB in Q4 2021 and has held it in 4 quarters since. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Surevest held 23 shares of Biogen worth $6K as of Q3 2022.
Surevest left its Biogen share count unchanged in Q3 2022.
Biogen made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #307 holding.
Surevest first reported a position in Biogen in Q4 2021 and has held it in 4 quarters since.
986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.